SCHEMBL1870929

SCHEMBL1870929

O=C(Nc1ccc(O)cc1)OCc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.71
TP53 P04637 2/20 0.65
MAPT P10636 2/20 0.65
KDM1A O60341 3/20 0.63
MAOA P21397 3/20 0.63
MAOB P27338 3/20 0.63
MGLL Q99685 2/20 0.63
RCOR1 Q9UKL0 2/20 0.62
ROCK2 O75116 2/20 0.62
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
ALDH1A1 P00352 1/20 0.59
TSHR P16473 1/20 0.59
ATM Q13315 1/20 0.59
LMNA P02545 1/20 0.57
GAA P10253 1/20 0.56
MIF P14174 1/20 0.56
ENPP2 Q13822 1/20 0.56
RECQL P46063 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9128045 0.95 ROCK2 (0.69) POLBTP53MAPTKDM1AMAOA
Benzyl Phenylcarbamate SCHEMBL1222943 0.91 POLB (0.78) POLBTP53MAPTKDM1AMAOA
SCHEMBL9125031 0.89 SMN1; SMN2 (0.59) POLBTP53MAPTKDM1AMAOA
SCHEMBL10598558 0.88 POLB (0.69) POLBTP53MAPTKDM1AMAOA
SCHEMBL10595799 0.87 POLB (0.73) POLBTP53MAPTKDM1AMAOA
SCHEMBL97634 0.87 POLB (0.68) POLBTP53MAPTKDM1AMAOA
SCHEMBL3795024 0.87 POLB (0.68) POLBTP53MAPTKDM1AMAOA
SCHEMBL3694153 0.87 POLB (0.68) POLBTP53MAPTKDM1AMAOA
SCHEMBL7663567 0.87 POLB (0.68) POLBTP53MAPTKDM1AMAOA
SCHEMBL5700992 0.87 POLB (0.68) POLBTP53MAPTKDM1AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1091432-A Can suppress the active peptide of hiv protease, its preparation with and medical use SANKYO CO (JP) 1994-08-31 CN claimed
US-20260000609-A1 METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES ROCK BIOMEDICAL INC (TW) 2026-01-01 US disclosed
EP-4568709-A2 METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES Rock Biomedical Inc. (TW) 2025-06-18 EP disclosed
US-12318485-B2 Methods and compositions for targeted delivery by polymersomes ROCK BIOMEDICAL, INC. (TW) 2025-06-03 US disclosed
US-20250041222-A1 METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES ROCK BIOMEDICAL INC. (TW) 2025-02-06 US disclosed
CN-119080631-A Method for preparing N-aryl amide compound by catalyzing nitrite-mediated selenium 浙江工业大学 2024-12-06 CN disclosed
CN-118880357-A Benzoxazine derivative and electrochemical synthesis method thereof 齐齐哈尔医学院 2024-11-01 CN disclosed
WO-2024215612-A2 METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES ROC BIOMEDICAL INC. (TW) 2024-10-17 WO disclosed
CN-116283916-B Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof 中国科学院上海药物研究所 2024-06-11 CN disclosed
US-20240124491-A1 METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA Design Therapeutics, Inc. 2024-04-18 US disclosed
WO-2000023076-A1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS SUNTORY LIMITED (JP) 2000-04-27 WO disclosed
CN-1246110-A Arylpiperidinopropanol and arylpiperazinopropanol derivatives and drugs containing the same SUNTORY LTD (JP) 2000-03-01 CN disclosed
EP-0958280-A1 ARYLPIPERIDINOPROPANOL AND ARYLPIPERAZINOPROPANOL DERIVATIVES AND PHARMACEUTICALS CONTAINING THE SAME SUNTORY LIMITED (JP) 1999-11-24 EP disclosed
WO-1999023072-A1 ARYLPIPERIDINOPROPANOL AND ARYLPIPERAZINOPROPANOL DERIVATIVES AND PHARMACEUTICALS CONTAINING THE SAME SUNTORY LIMITED (JP) 1999-05-14 WO disclosed
EP-0632019-B1 Acylureas ZENECA LTD (GB) 1997-09-24 EP disclosed
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
US-5576334-A ANTICOAGULANTS ZENECA LIMITED (GB) 1996-11-19 US disclosed
EP-0632019-A1 Acylureas ZENECA LIMITED (GB) 1995-01-04 EP disclosed
CN-1091432-A Can suppress the active peptide of hiv protease, its preparation with and medical use SANKYO CO (JP) 1994-08-31 CN disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124491-A1 METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA ATXN2, ATXN2L, CDR2 POLB 45/4885TP53 2399/4885MAPT 2092/4885
US-12318485-B2 Methods and compositions for targeted delivery by polymersomes ALG1, CHMP4B, ALG8 POLB 96/4885TP53 847/4885MAPT 629/4885
US-20260000609-A1 METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES CD2, CLEC4M, CD47 POLB 2622/4885TP53 994/4885MAPT 1026/4885
US-20250041222-A1 METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES ALG1, CHMP4B, ALG8 POLB 96/4885TP53 847/4885MAPT 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.